Countries China
CBC Group continues to expand its global healthcare ecosystem to fulfil unmet medical needs
Hasten fast-tracks transformative medicines for patients in China Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has ...
April 01, 2022 | News
Biocytogen Expands Global Footprint
Local government representatives, clinical experts, and colleagues and collaborators from multi-national companies made speeches at the opening ceremony. D...
March 29, 2022 | News
Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG
Furthermore, it also empowers the domestic precision immunotherapy for tumors and promotes the high-quality development of China's biopharmaceuti...
March 28, 2022 | News
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia
The MOH Malaysia recommends using Convidecia™ as a heterologous booster for individuals aged 18 and above who have been administered two doses of ina...
March 23, 2022 | News
WuXi Biologics Achieved Record Growth and Profitability in 2021
WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group," stock code: 2269.HK), a global Contract Research, Development and Manufacturing Organization...
March 23, 2022 | News
Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules
These experimental results show that Lianhua Qingwen Capsules have significant inhibiting effect on the cytopathic effect induced by Omicron variant so as ...
March 22, 2022 | News
China CDE Approved First Universal CAR-T IND !
"The approval of CTA101 product IND is an important milestone for Bioheng in developing innovative immuno-cell therapies", said Xiaohong He, CEO of Bi...
March 18, 2022 | News
Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership
Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...
March 18, 2022 | News
China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors
-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...
March 14, 2022 | News
Sinocompound announces commercial-scale production of QPhos ligand
Sinocompound Catalysts Co., Ltd, a global provider of advanced homogeneous catalysts and ligands, has announced production of the phosphine-based QPhos lig...
March 14, 2022 | News
Everest Medicines to further enhance its international commercial footprint
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...
March 14, 2022 | News
Singleron Acquires Proteona
Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their...
March 08, 2022 | News
WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site
The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection from Novembe...
March 04, 2022 | News
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark f...
February 25, 2022 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
